Navigation Links
Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
Date:5/24/2012

PITTSBURGH, POTTERS BAR, England and MILAN, May 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its UK and Italy-based subsidiaries have launched Ibandronic Acid Film Coated Tablets POM, 150 mg. This product is the generic version of Roche's Bonviva® Tablets, a treatment for osteoporosis(1).

Mylan CEO Heather Bresch said: "This launch represents another day-one generic for Mylan's businesses in the UK and Italy. We are excited to be adding generic Ibandronic Acid to our strong portfolio of more than 350 products in the UK and 340 products in Italy, as we continue to deliver on our commitment of providing high quality and affordable medicines to patients around the world."

Ibandronic Acid Film Coated Tablets POM had sales of approximately 8.5 million euros (7.5 million pounds Sterling) in the UK and sales of approximately 27 million euros in Italy for the 12 months ending March 2012, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com  

(1) Treatment of osteoporosis in postmenopausal women at increased risk of fracture. A reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... VIEW, Calif. (PRWEB) , ... May 21, 2020 , ... ... emergency and critical care veterinary hospital located at 601 Showers Dr., Mountain View, CA ... Valley to further expand access for pet care in the Silicon Valley and broader ...
(Date:5/21/2020)... PLEASANTON, Calif. (PRWEB) , ... May 21, 2020 ... ... (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced ... as a UroLift® Center of Excellence. The designation recognizes that Dr. Divakaruni has ...
(Date:5/17/2020)... ... May 17, 2020 , ... The Sea Cucumber-derived triterpenoid glycoside ... beneficial properties is extracted from the Sea Cucumber in a proprietary process to give ... , You’ve heard it time and time again: “You get what you pay for.” ...
Breaking Medicine Technology:
(Date:5/16/2020)... N.C. (PRWEB) , ... May 15, 2020 , ... On May 21, T1V will host ... the Ellison Institute of USC, and a contributor to CBS news, as we address COVID-19 ... in place in most parts of the country since March, many questions are left unanswered ...
(Date:5/16/2020)... ... May 16, 2020 , ... Dr. Tomasz Biernacki states that ... permanent arthritis from developing. This can keep the foot from being unable to fit ... estimated that the people who develop flat feet and bunion formation can ...
(Date:5/15/2020)... (PRWEB) , ... May 15, 2020 , ... Collagen has ... in the natural channel alone in 2019, according to a 2020 Nutritional Outlook ‘Ingredients ... – moving further and further away from the high molecular weight, low-impact products of ...
(Date:5/15/2020)... ... , ... On May 17, World NF Awareness Day, actors, musicians, comedians, chefs, ... benefit to support the Children’s Tumor Foundation and to Make NF Visible. NF, short ... throughout the body and affects all ethnicities, races, and genders equally. In addition to ...
(Date:5/15/2020)... ... May 15, 2020 , ... AdventHealth Tampa, the flagship ... hospital’s new six-story, 300,000 square foot patient and surgical tower Friday, May 15, ... off celebrates the structural completion of the $256 million project. Construction on the ...
Breaking Medicine News(10 mins):